$2.26T
Total marketcap
$127.78B
Total volume
BTC 50.02%     ETH 15.46%
Dominance

Coloplast A/S CBH.F Stock

12.4 EUR {{ price }} 1.639343% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
27.88B EUR
LOW - HIGH [24H]
12.4 - 12.4 EUR
VOLUME [24H]
2 EUR
{{ volume }}
P/E Ratio
41.33
Earnings per share
0.3 EUR

Coloplast A/S Price Chart

Coloplast A/S CBH.F Financial and Trading Overview

Coloplast A/S stock price 12.4 EUR
Previous Close 11.1 EUR
Open 11.2 EUR
Bid 11.5 EUR x N/A
Ask 11.9 EUR x N/A
Day's Range 11.2 - 11.2 EUR
52 Week Range 9.6 - 13.4 EUR
Volume 50 EUR
Avg. Volume 14 EUR
Market Cap 24.09B EUR
Beta (5Y Monthly) 0.283908
PE Ratio (TTM) 36.129032
EPS (TTM) 0.3 EUR
Forward Dividend & Yield 0.27 (2.35%)
Ex-Dividend Date May 19, 2023
1y Target Est N/A

CBH.F Valuation Measures

Enterprise Value 44.79B EUR
Trailing P/E 36.129032
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.0006912
Price/Book (mrq) 3.382153
Enterprise Value/Revenue 1.861
Enterprise Value/EBITDA 5.764

Trading Information

Coloplast A/S Stock Price History

Beta (5Y Monthly) 0.283908
52-Week Change 16.06%
S&P500 52-Week Change 20.43%
52 Week High 13.4 EUR
52 Week Low 9.6 EUR
50-Day Moving Average 12.14 EUR
200-Day Moving Average 11.18 EUR

CBH.F Share Statistics

Avg. Volume (3 month) 14 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 2.12B
Float 1.31B
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.016%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 20
Trailing Annual Dividend Yield 180.18%
5 Year Average Dividend Yield N/A
Payout Ratio 0.8904
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 19.94%
Operating Margin (ttm) 29.19%
Gross Margin 68.08%
EBITDA Margin 32.28%

Management Effectiveness

Return on Assets (ttm) 12.46%
Return on Equity (ttm) 67.11%

Income Statement

Revenue (ttm) 24.07B EUR
Revenue Per Share (ttm) 11.34 EUR
Quarterly Revenue Growth (yoy) 10.19%
Gross Profit (ttm) 15.53B EUR
EBITDA 7.77B EUR
Net Income Avi to Common (ttm) 4.8B EUR
Diluted EPS (ttm) 0.31
Quarterly Earnings Growth (yoy) 17.89%

Balance Sheet

Total Cash (mrq) 644M EUR
Total Cash Per Share (mrq) 0.3 EUR
Total Debt (mrq) 21.65B EUR
Total Debt/Equity (mrq) 307.76 EUR
Current Ratio (mrq) 0.988
Book Value Per Share (mrq) 3.3115

Cash Flow Statement

Operating Cash Flow (ttm) 4.89B EUR
Levered Free Cash Flow (ttm) 3.36B EUR

Profile of Coloplast A/S

Country Germany
State N/A
City Humlebæk
Address Holtedam 1-3
ZIP 3050
Phone 45 49 11 11 11
Website https://www.coloplast.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 14973

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Q&A For Coloplast A/S Stock

What is a current CBH.F stock price?

Coloplast A/S CBH.F stock price today per share is 12.4 EUR.

How to purchase Coloplast A/S stock?

You can buy CBH.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Coloplast A/S?

The stock symbol or ticker of Coloplast A/S is CBH.F.

Which industry does the Coloplast A/S company belong to?

The Coloplast A/S industry is Medical Instruments & Supplies.

How many shares does Coloplast A/S have in circulation?

The max supply of Coloplast A/S shares is 2.25B.

What is Coloplast A/S Price to Earnings Ratio (PE Ratio)?

Coloplast A/S PE Ratio is 41.33333200 now.

What was Coloplast A/S earnings per share over the trailing 12 months (TTM)?

Coloplast A/S EPS is 0.3 EUR over the trailing 12 months.

Which sector does the Coloplast A/S company belong to?

The Coloplast A/S sector is Healthcare.